HLA-G and cancer: For example, HLA-G molecules exist at high levels in the tumor environment and have excellent potential to become immune checkpoint therapy (Attia et al., 2020; Loustau et al., 2020); the silent mutation or deletion of HLA molecules has proved to be a relatively common phenomenon in cancer (Shukla et al., 2015).